Tran­si­tion to new Eu­ro­pean clin­i­cal tri­als in­fo sys­tem starts slow­ly

4 years ago
R&D

Switzer­land to de­stroy over 600,000 ex­pired dos­es of Mod­er­na Covid vac­cine

4 years ago
Pharma
Coronavirus

Sen­ate un­veils its ver­sion of ac­cel­er­at­ed ap­proval re­forms as bi­par­ti­san duo calls on FDA and PTO to work to­geth­er

4 years ago
FDA+
Law

Vi­iV Health­care looks to make long-act­ing HIV pre­ven­tion shot ac­ces­si­ble in low- and mid­dle-in­come coun­tries

4 years ago
Pharma

EU re­port­ed­ly eye­ing vac­cines deal for mon­key­pox out­break; Nas­daq tells Mereo to get stock price up or face delist­ing

4 years ago
News Briefing

Guardant Health fires back at Il­lu­mi­na suit, claim­ing re­tal­i­a­tion over its role in FTC an­titrust in­ves­ti­ga­tion

4 years ago
Diagnostics
Law

AS­CO ab­stracts mint some ear­ly win­ners, but Io­vance, Spring­Works get hit by mas­sive loss­es

4 years ago
R&D

Covid-19 roundup: CDC study shows good pro­tec­tion from mR­NA boost­er plus J&J's sin­gle-dose vac­cine; White House ...

4 years ago
Coronavirus

Look out, Neu­las­ta: A 5th biosim­i­lar is com­ing

4 years ago
Pharma
FDA+

Af­ter $60M Ver­tex deal, group of Cat­a­lyst share­hold­ers claims biotech could’ve sold as­sets three years ago

4 years ago
Deals

Keep­ing pres­sure on Am­gen, Mi­rati draws mixed re­views on lat­est cut of KRAS da­ta

4 years ago
R&D

Roche's CD20xCD3 does­n't beat Gen­mab at ORR, but sets bar for CR da­ta on lym­phoma drug

4 years ago
R&D
Pharma

Al­ways chas­ing the newest sci­ence, Schond Green­way joins MindMed; Mi­rati fills key va­can­cy with ex-Are­na fi­nance ...

4 years ago
Peer Review

Pair of ex-HHS coun­sels crit­i­cize bill to 'u­pend' 180-day ex­clu­siv­i­ty for first gener­ic drugs

4 years ago
Pharma

Pile-on over PBMs con­tin­ues with FTC com­ments and a new bi­par­ti­san Sen­ate bill

4 years ago
Pharma

Bris­tol My­ers Squibb re­fresh­es Eliquis cam­paign, adds eye-catch­ing an­i­ma­tions in TV ads

4 years ago
Pharma
Marketing

Phar­ma brands fade in an­nu­al Har­ris con­sumer vis­i­bil­i­ty poll: Mod­er­na drops off and Pfiz­er dips

4 years ago
Pharma
Marketing

HHS fin­ish­es off Trump-era rule that would've erased ba­sic FDA regs with­out fre­quent re­views

4 years ago
Pharma
FDA+

Servi­er ex­pands Tib­so­vo la­bel with first com­bi­na­tion OK in a rare form of AML

4 years ago
Pharma
FDA+

Se­quoia Chi­na leads $37M in­fu­sion in­to ra­dio­phar­ma­ceu­ti­cals play­er set­ting up shop in Chi­na and Bel­gium

4 years ago
Financing
Startups

Biotech SPAC takes IPO goal down a notch; Africa’s top health agency warns against mon­key­pox vac­cine hoard­ing

4 years ago
News Briefing

Two years post-stealth ex­it, high­ly se­cre­tive in­flam­ma­tion biotech se­cures fi­nal tranche of Se­ries A round

4 years ago
Financing

In search of elu­sive NASH break­through, Pfiz­er spot­lights com­bo ap­proach

4 years ago
R&D

Long­time Kad­mon con­sul­tant slapped with in­sid­er trad­ing charges re­lat­ed to $1.9B Sanofi buy­out

4 years ago
Pharma
Law
First page Previous page 523524525526527528529 Next page Last page
A service from the Financial Times